GUT MICROBIOTA AND RECURRENT UPPER RESPIRATORY TRACT INFECTIONS: EMERGING IMPLICATIONS FOR OTOLARYNGOLOGY

Wiktoria Pempuś; Inga  Jakubczyk; Kacper Szkodziński; Jagoda Maternia; Aleksandra Łoś; Karolina Majowicz-Czaszyńska; Nikola Król; Barbara Tomaszek; Aleksandra  Blok; Dominik Wiater; Gabriela Płodzień

doi:10.31435/ijitss.3(51).2026.5782

Authors

Wiktoria Pempuś Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0000-0002-5410-0766
Inga Jakubczyk Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0004-6982-3213
Kacper Szkodziński University Clinical Hospital F. Chopin in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0009-1161-129X
Jagoda Maternia Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0000-9614-118X
Aleksandra Łoś Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0000-5094-1157
Karolina Majowicz-Czaszyńska Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0002-3240-8564
Nikola Król Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0000-0002-5524-6476
Barbara Tomaszek The Independent Public Healthcare Institution in Przeworsk, Przeworsk, Poland https://orcid.org/0009-0001-8477-0007
Aleksandra Blok The Independent Public Healthcare Institution in Przeworsk, Przeworsk, Poland https://orcid.org/0009-0001-0813-0366
Dominik Wiater University Clinical Hospital F. Chopin in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0005-3761-5118
Gabriela Płodzień Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0008-2193-9312

DOI:

https://doi.org/10.31435/ijitss.3(51).2026.5782

Keywords:

Gut–Lung Axis, Intestinal Dysbiosis, Microbiota, Recurrent ENT Infections, Mucosal Immunity, Probiotics

Abstract

Recurrent upper respiratory tract infections (URTIs) represent a significant clinical challenge in otolaryngology, with growing evidence suggesting that intestinal microbiota may play an important role in their pathogenesis. The gut-lung axis describes bidirectional immunological, metabolic, and microbial communication between the gastrointestinal and respiratory systems. Disturbances in gut microbiota composition, known as dysbiosis, can impair mucosal immunity through altered IgA production, reduced regulatory T‑cell activity, and decreased levels of immunomodulatory metabolites such as short‑chain fatty acids. These changes may increase susceptibility to infections of the pharynx, sinuses, and middle ear, contributing to their chronic and recurrent course. Frequent antibiotic use, common in ENT practice, may further exacerbate dysbiosis, creating a potential vicious cycle of recurrent infections. Emerging therapeutic strategies - such as probiotics, prebiotics, dietary interventions, and personalized microbiome‑based approaches - offer promising but yet insufficiently validated avenues for supporting standard treatment. Further prospective clinical studies are required to better define the role of the gut-lung axis in the development and management of recurrent ENT infections and to assess the effectiveness of microbiome‑modulating therapies.

References

Budden, K. F., Gellatly, S. L., Wood, D. L. A., Cooper, M. A., Morrison, M., Hugenholtz, P., & Hansbro, P. M. (2017). Emerging pathogenic links between microbiota and the gut-lung axis. Nature Reviews Microbiology, 15(1), 55–63. https://doi.org/10.1038/nrmicro.2016.142

Dang, A. T., & Marsland, B. J. (2019). Microbes, metabolites, and the gut-lung axis. Mucosal Immunology, 12(4), 843–850. https://doi.org/10.1038/s41385-019-0160-6

Enaud, R., Prevel, R., Ciarlo, E., Beaufils, F., Wieërs, G., Guery, B., & Delhaes, L. (2020). The gut-lung axis in health and respiratory diseases: A place for inter-organ and inter-kingdom crosstalks. Frontiers in Cellular and Infection Microbiology, 10, 9. https://doi.org/10.3389/fcimb.2020.00009

Marsland, B. J., Trompette, A., & Gollwitzer, E. S. (2015). The gut-lung axis in respiratory disease. Annals of the American Thoracic Society, 12(Suppl. 2), S150–S156. https://doi.org/10.1513/AnnalsATS.201503-133AW

Yildiz, S., Mazel-Sanchez, B., Kandasamy, M., Manney, M. O., & Choi, S. (2021). The respiratory tract microbiome and its role in disease. Frontiers in Microbiology, 12, 686124. https://doi.org/10.3389/fmicb.2021.686124

Man, W. H., de Steenhuijsen Piters, W. A. A., & Bogaert, D. (2017). The microbiota of the respiratory tract: Gatekeeper to respiratory health. Nature Reviews Microbiology, 15(5), 259–270. https://doi.org/10.1038/nrmicro.2017.14

Chiu, C., & Miller, S. A. (2017). Clinical microbiome studies in respiratory disease. Journal of Allergy and Clinical Immunology, 140(1), 5–12. https://doi.org/10.1016/j.jaci.2017.05.023

Cho, I., & Blaser, M. J. (2012). The human microbiome: At the interface of health and disease. Nature Reviews Genetics, 13(4), 260–270. https://doi.org/10.1038/nrg3182